In multivariate analysis, we adjusted for age, gender, hepatitis etiology, first-line ICI regimen, Cancer of the Liver Italian Program scores (including Child–Pugh score, tumor morphology, liver involvement extent, and serum alpha-fetoprotein levels), and tumor status before initiation of second-line therapy. This evidence concerns the gene AFP and Hepatitis.